Opportunity Information: Apply for PAR 17 086

The Tobacco Use and HIV in Low and Middle Income Countries (R21) funding opportunity (PAR-17-086) is a National Institutes of Health (NIH) discretionary grant designed to support early-stage, exploratory, and developmental research at the intersection of tobacco use and HIV in low and middle income countries (LMICs). The central goal is to generate practical, testable ideas and preliminary evidence that can improve tobacco-related outcomes among people living with HIV in settings where healthcare resources, staffing, and infrastructure may be limited. The announcement emphasizes work that is directly relevant to LMIC contexts, where both tobacco exposure and HIV burden can be substantial, and where standard cessation approaches used in higher-resource environments may not be feasible, affordable, or culturally appropriate without thoughtful adaptation.

A major focus of the opportunity is the development and evaluation of tobacco cessation interventions tailored specifically to HIV-positive populations. This includes interventions that fit into real-world HIV care delivery systems and respond to the needs of patients whose clinical and social circumstances may make quitting more difficult. The FOA explicitly encourages projects that consider co-morbidities such as tuberculosis (TB), recognizing that TB and HIV co-infection is a major public health challenge in many LMICs and that tobacco use can worsen respiratory health, complicate treatment, and contribute to poorer outcomes. In practice, responsive projects might explore how to integrate cessation support into HIV or TB clinics, how to train available cadres of health workers to deliver brief cessation counseling, how to adapt pharmacologic or behavioral supports to low-resource settings, or how to address barriers such as stigma, mental health stressors, or inconsistent access to medications and follow-up care.

Because this is an R21 mechanism, the FOA is oriented toward exploratory and developmental work rather than large-scale definitive trials. It supports key early steps needed to move an intervention or implementation approach forward, including research planning activities, the actual delivery of an intervention, and follow-up activities to assess outcomes and feasibility. In other words, the grant can cover the practical arc of pilot testing: preparing and tailoring an approach for the local setting, implementing it in a defined population, and collecting follow-up data to understand whether it is acceptable, workable, and promising enough to justify a larger study later.

The opportunity is categorized under Education and Health and is associated with CFDA numbers 93.279 and 93.393. The award ceiling listed is $200,000. The original closing date shown in the source information is January 7, 2020, and the posting (creation) date is December 15, 2016. Applicants should note that these dates indicate the opportunity as originally published and may require verification of current availability or re-issuance if pursuing a similar funding line today.

Eligibility is broad and spans many organization types, reflecting NIH’s intent to encourage diverse partnerships and applicant pools, including those with deep community roots or direct operational presence in LMIC health systems. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations and tribal governments other than federally recognized entities; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); and small businesses. The FOA also highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, U.S. territories or possessions, regional organizations, and non-domestic (non-U.S.) entities (foreign organizations). This breadth is especially relevant for LMIC-focused research, where partnerships between U.S.-based institutions and in-country organizations, ministries of health, universities, clinics, or community groups are often essential for ethical engagement, feasibility, and long-term impact.

Overall, this FOA targets practical, context-aware research that helps close a critical gap in global health: addressing tobacco use among people living with HIV in LMICs through interventions that can realistically be delivered in low-resource environments. By supporting planning, pilot implementation, and follow-up, it aims to create a pipeline of well-grounded interventions and implementation strategies that can later be scaled or tested more rigorously, ultimately improving HIV-related health outcomes and reducing tobacco-related disease burden in vulnerable populations.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Tobacco Use and HIV in Low and Middle Income Countries (R21)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279, 93.393.
  • This funding opportunity was created on 2016-12-15.
  • Applicants must submit their applications by 2020-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $200,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 17 086

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

What is the Tobacco Use and HIV in Low and Middle Income Countries (R21) funding opportunity?

It is a National Institutes of Health (NIH) discretionary grant opportunity (PAR-17-086) that supports early-stage, exploratory, and developmental research focused on the intersection of tobacco use and HIV in low and middle income countries (LMICs).

What is the main goal of this grant?

The central goal is to generate practical, testable ideas and preliminary evidence that can improve tobacco-related outcomes among people living with HIV in LMIC settings, particularly where healthcare resources, staffing, and infrastructure may be limited.

What types of research does this opportunity prioritize?

The opportunity emphasizes research that is directly relevant to LMIC contexts and that addresses the real-world challenges of reducing tobacco use among HIV-positive populations, including the need to adapt approaches that may not be feasible, affordable, or culturally appropriate in low-resource environments without thoughtful tailoring.

Does the FOA focus specifically on tobacco cessation interventions?

Yes. A major focus is the development and evaluation of tobacco cessation interventions tailored to HIV-positive populations, including interventions that can fit into HIV care delivery systems and respond to patient needs that may make quitting more difficult.

Are projects expected to be designed for real-world HIV care settings in LMICs?

Yes. The announcement highlights interventions that integrate into real-world HIV care delivery systems in LMICs, where constraints in resources and infrastructure can affect what is practical to deliver.

How does tuberculosis (TB) fit into the scope of this opportunity?

The FOA explicitly encourages projects that consider co-morbidities such as tuberculosis (TB), recognizing that TB and HIV co-infection is a major public health challenge in many LMICs and that tobacco use can worsen respiratory health, complicate treatment, and contribute to poorer outcomes.

What are examples of project approaches that would align with this FOA?

Examples described as responsive include integrating cessation support into HIV or TB clinics, training available health worker cadres to deliver brief cessation counseling, adapting pharmacologic or behavioral supports for low-resource settings, and addressing barriers such as stigma, mental health stressors, and inconsistent access to medications and follow-up care.

What does the R21 mechanism mean for the scope of the work?

Because this is an R21 mechanism, the FOA is oriented toward exploratory and developmental work rather than large-scale, definitive trials. It supports early steps needed to move an intervention or implementation approach forward.

Can the grant support planning, pilot implementation, and follow-up activities?

Yes. The FOA supports research planning activities, the delivery of an intervention, and follow-up activities to assess outcomes and feasibility. It is intended to cover the practical arc of pilot testing: tailoring an approach, implementing it in a defined population, and collecting follow-up data on acceptability, workability, and promise.

What is the award ceiling listed for this opportunity?

The award ceiling listed is $200,000.

What is the program/FOA identifier for this opportunity?

The funding opportunity is identified as PAR-17-086.

Which agency is offering this funding opportunity?

The opportunity is offered through the National Institutes of Health (NIH).

What category is this opportunity listed under?

The opportunity is categorized under Education and Health.

What CFDA numbers are associated with this opportunity?

The opportunity is associated with CFDA numbers 93.279 and 93.393.

What were the original posting and closing dates shown for this opportunity?

The posting (creation) date shown is December 15, 2016, and the original closing date shown is January 7, 2020.

Should applicants verify whether this funding opportunity is still available?

Yes. The dates provided indicate the opportunity as originally published, and applicants may need to verify current availability or whether the opportunity has been re-issued if pursuing a similar funding line today.

Who is eligible to apply?

Eligibility is broad and includes many organization types, such as state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations and tribal governments other than federally recognized entities; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); and small businesses.

Are non-U.S. (foreign) organizations eligible to apply?

Yes. The FOA includes non-domestic (non-U.S.) entities (foreign organizations) among eligible applicants.

Does the FOA encourage participation from institutions serving specific populations?

Yes. The FOA highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs).

Are faith-based or community-based organizations eligible?

Yes. Faith-based or community-based organizations are specifically listed among additional eligible applicants.

Are U.S. territories or possessions and regional organizations eligible?

Yes. The FOA includes U.S. territories or possessions and regional organizations among eligible applicants.

Why does the FOA emphasize LMIC settings?

The FOA emphasizes LMIC settings because both tobacco exposure and HIV burden can be substantial in these contexts, and standard cessation approaches used in higher-resource environments may not translate well without adaptation to local feasibility, affordability, and cultural appropriateness.

What kind of impact is this FOA ultimately aiming for?

It aims to help close a gap in global health by advancing context-aware research and building a pipeline of grounded interventions and implementation strategies that can later be scaled or tested more rigorously to improve HIV-related outcomes and reduce tobacco-related disease burden.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Reducing Health Disparities Among Minority and Underserved Children (R21)

Previous opportunity: Pilot Clinical Trials in Pediatric Chronic Kidney Disease Participating Clinical Centers (U01)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 17 086

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 17 086) also looked into and applied for these:

Funding Opportunity
NLM Administrative Supplements for Informationist Services in NIH-funded Research Projects (Admin Supp) Apply for PA 17 090

Funding Number: PA 17 090
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $25,000
Cancer Immune Monitoring and Analysis Centers (U24) Apply for RFA CA 17 005

Funding Number: RFA CA 17 005
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,400,000
Cancer Immunologic Data Commons (CIDC) (U24) Apply for RFA CA 17 006

Funding Number: RFA CA 17 006
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $900,000
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30) Apply for PAR 17 095

Funding Number: PAR 17 095
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Jointly Sponsored Ruth L. Kirschstein National Research Service Award for Institutional Predoctoral Training Programs in the Neurosciences (T32) Apply for PAR 17 096

Funding Number: PAR 17 096
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Implementation Science for the Prevention and Treatment of Mental and/or Substance use Disorders in Low- and Middle-income Countries (U01) Apply for RFA MH 17 650

Funding Number: RFA MH 17 650
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $425,000
HIV-1 infection of the Central Nervous System (R01) Apply for PA 17 100

Funding Number: PA 17 100
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Neuroscience Research on Drug Abuse (R01) Apply for PA 17 111

Funding Number: PA 17 111
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Neuroscience Research on Drug Abuse (R21) Apply for PA 17 112

Funding Number: PA 17 112
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R21) Apply for PA 17 109

Funding Number: PA 17 109
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Chronic Condition Self-Management in Children and Adolescents (R01) Apply for PA 17 115

Funding Number: PA 17 115
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NIDA Core "Center of Excellence" Grant Program (P30) Apply for PAR 17 121

Funding Number: PAR 17 121
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Reducing Health Disparities Among Minority and Underserved Children (R21) Apply for PA 17 117

Funding Number: PA 17 117
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Reducing Health Disparities Among Minority and Underserved Children (R01) Apply for PA 17 118

Funding Number: PA 17 118
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Chronic Condition Self-Management in Children and Adolescents (R21) Apply for PA 17 116

Funding Number: PA 17 116
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R01) Apply for PA 17 110

Funding Number: PA 17 110
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Discovering Novel Targets: The Molecular Genetics of Drug Addiction and Related Co-Morbidities (R01) Apply for PA 17 120

Funding Number: PA 17 120
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Basic Mechanisms of Brain Development Mediating Substance Use and Dependence (R01) Apply for PA 17 119

Funding Number: PA 17 119
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Perception and Cognition Research to Inform Cancer Image Interpretation (R21) Apply for PAR 17 124

Funding Number: PAR 17 124
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Perception and Cognition Research to Inform Cancer Image Interpretation (R01) Apply for PAR 17 125

Funding Number: PAR 17 125
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 17 086", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: